» Articles » PMID: 34505975

Lactobacillus Rhamnosus Affects Rat Peritoneal Cavity Cell Response to Stimulation with Gut Microbiota: Focus on the Host Innate Immunity

Overview
Journal Inflammation
Date 2021 Sep 10
PMID 34505975
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Gut microbiota contribute to shaping the immune repertoire of the host, whereas probiotics may exert beneficial effects by modulating immune responses. Having in mind the differences in both the composition of gut microbiota and the immune response between rats of Albino Oxford (AO) and Dark Agouti (DA) rat strains, we investigated if intraperitoneal (i.p.) injection of live Lactobacillus rhamnosus (LB) may influence peritoneal cavity cell response to in vitro treatments with selected microbiota in the rat strain-dependent manner. Peritoneal cavity cells from AO and DA rats were lavaged two (d2) and seven days (d7) following i.p. injection with LB and tested for NO, urea, and HO release basally, or upon in vitro stimulation with autologous E.coli and Enterococcus spp. Whereas the single i.p. injection of LB nearly depleted resident macrophages and increased the proportion of small inflammatory macrophages and monocytes on d2 in both rat strains, greater proportion of MHCIICD163 and CCR7 cells and increased NO/diminished HO release in DA compared with AO rats suggest a more intense inflammatory priming by LB in this rat strain. Even though E.coli- and/or Enterococcus spp.-induced rise in HO release in vitro was abrogated by LB in cells from both rat strains, LB prevented microbiota-induced increase in NO/urea ratio only in cells from AO and augmented it in cells from DA rats. Thus, the immunomodulatory properties may not be constant for particular probiotic bacteria, but shaped by innate immunity of the host.

Citing Articles

Long-Term Treatment with Alcaligenes faecalis A12C Improves Host Resistance to Pathogens in Septic Rats: Possible Contribution of Curdlan-Like Immune Trainer.

Martel-Benitez C, Alayon-Afonso R, Castillo D, Chamizo-Lopez F, Garcia-Laorden M, de Los Monteros Y Zayas A Probiotics Antimicrob Proteins. 2024; .

PMID: 38668821 DOI: 10.1007/s12602-024-10252-0.


Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant .

Li Y, Peng Y, Zhang N, Liu H, Mao J, Yan Y Infect Drug Resist. 2022; 15:4995-5010.

PMID: 36065277 PMC: 9440711. DOI: 10.2147/IDR.S377848.

References
1.
Cani P, Osto M, Geurts L, Everard A . Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012; 3(4):279-88. PMC: 3463487. DOI: 10.4161/gmic.19625. View

2.
Lerner A, Matthias T . Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling. Autoimmun Rev. 2015; 14(11):1038-47. DOI: 10.1016/j.autrev.2015.07.007. View

3.
Clarke T, Davis K, Lysenko E, Zhou A, Yu Y, Weiser J . Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010; 16(2):228-31. PMC: 4497535. DOI: 10.1038/nm.2087. View

4.
Emani R, Alam C, Pekkala S, Zafar S, Emani M, Hanninen A . Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice. Scand J Immunol. 2014; 81(2):102-9. DOI: 10.1111/sji.12253. View

5.
Blagojevic V, Kovacevic-Jovanovic V, Curuvija I, Petrovic R, Vujnovic I, Vujic V . Rat strain differences in peritoneal immune cell response to selected gut microbiota: A crossroad between tolerance and autoimmunity?. Life Sci. 2018; 197:147-157. DOI: 10.1016/j.lfs.2018.02.011. View